BI 201335: Phase Ib data

The open-label Phase Ib SOUND-C1 trial in 32 treatment-naïve patients with HCV genotype 1 infection showed that thrice-daily 400 and 600 mg oral BI 207127 in combination with once-daily 120 mg oral B...